Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies', we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies', only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Lennard Lee, one of OUCAGS’ clinical lecturers, has been awarded the 2020 ACP McElwain Prize for contributions to medical oncology in the UK.

During the current COVID-19 pandemic, Dr Lee, a medical oncologist, created and implemented a national prospective observational cohort study of cancer patients, the UK Coronavirus Cancer Monitoring Project (UK CCMP). The study was the first to identify that cancer treatments could be safely administered during the pandemic, as published in The Lancet.

Dr Lennard Lee said: ‘No one should be denied appropriate cancer treatments and it is important that we continue to deliver research excellence in order to protect the vulnerable during this pandemic.’

Dr Lee also said that he is extremely grateful to OUCAGS for the academic/clinical and mentorship support during his clinical lectureship.

Dr Lennard Lee

View Dr Lee’s profile on the OUCAGS website